- Home
- IPW vs AIMD Comparison
IPW vs AIMD Comparison
Compare IPW & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPW
- AIMD
- Stock Information
- Founded
- IPW 2018
- AIMD 1984
- Country
- IPW United States
- AIMD United States
- Employees
- IPW N/A
- AIMD N/A
- Industry
- IPW Catalog/Specialty Distribution
- AIMD Biotechnology: Pharmaceutical Preparations
- Sector
- IPW Consumer Discretionary
- AIMD Health Care
- Exchange
- IPW Nasdaq
- AIMD Nasdaq
- Market Cap
- IPW 16.3M
- AIMD 16.9M
- IPO Year
- IPW 2021
- AIMD N/A
- Fundamental
- Price
- IPW $0.54
- AIMD $3.88
- Analyst Decision
- IPW
- AIMD
- Analyst Count
- IPW 0
- AIMD 0
- Target Price
- IPW N/A
- AIMD N/A
- AVG Volume (30 Days)
- IPW 2.9M
- AIMD 76.4K
- Earning Date
- IPW 11-13-2025
- AIMD 11-05-2025
- Dividend Yield
- IPW N/A
- AIMD N/A
- EPS Growth
- IPW N/A
- AIMD N/A
- EPS
- IPW N/A
- AIMD N/A
- Revenue
- IPW $74,105,251.00
- AIMD $110,870.00
- Revenue This Year
- IPW $8.31
- AIMD N/A
- Revenue Next Year
- IPW $77.15
- AIMD N/A
- P/E Ratio
- IPW N/A
- AIMD N/A
- Revenue Growth
- IPW N/A
- AIMD 70.25
- 52 Week Low
- IPW $0.41
- AIMD $2.00
- 52 Week High
- IPW $2.05
- AIMD $5.00
- Technical
- Relative Strength Index (RSI)
- IPW 50.06
- AIMD 61.77
- Support Level
- IPW $0.50
- AIMD $3.46
- Resistance Level
- IPW $0.58
- AIMD $3.95
- Average True Range (ATR)
- IPW 0.09
- AIMD 0.20
- MACD
- IPW 0.00
- AIMD 0.01
- Stochastic Oscillator
- IPW 7.58
- AIMD 89.24
About IPW iPower Inc.
iPower Inc is online hydroponic equipment and accessory retailer and supplier in North America. The company sells products through own website as well as online channel partners that include Amazon, Walmart, and eBay.
About AIMD Ainos Inc.
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.